$BRKB Berkshire Hathaway ranked positive on Jan 7th

Ronald Olson (Non-Executive Director since 1997) purchased $889,000 of Class B shares on the 18th of December at $222.33. His trading record in the stock is reasonable and this is notable as, whilst it’s fairly typical in size for him, it’s his first purchase since December 2012 when he bought stock at $90. He owns […]

Read More

$SPLP US Steel Partners Holdings ranked positive on Dec 30th 20

Jack Howard (President since 2009) purchased $726,000 of stock on the 29th December, this his first purchase despite his long tenure but his trades in other companies are sufficiently strong for him to qualify as a “Smart Buyer”. Warren Lichtenstein (Chair since 2009) purchased $1 million of stock also on the 29th December, the trade […]

Read More

$VST US Vistra Corp ranked positive on Dec 21st 2020

James Burke (CFO, joined 2016) purchased 17,000 shares on December 16th at $18.25, spending $310,000. The purchase increased his holdings by 10% to 203,000 shares and is his largest purchase in the stock. We ranked this stock +N on September 9th based on a $750,000 purchase from the CEO at $18.18, which also was his […]

Read More

$UHAL US Amerco ranked positive on Dec 17th 20

Edward Shoen (Chair and CEO since 1987) purchased $2.1 million of stock on the 15th December at $428.55. His previous buys, such as in 2009 have been well timed and whilst he started buying too early in 2020 he continued to average down and ultimately those trades worked out very well. This latest purchase, through […]

Read More

$ATCX US Atlas Technical Corp ranked positive on Dec 8th 2020

Walter Powell (Chief Accounting Officer since 2017) purchased $194,000 of stock on the 4th December at $6.81 in his first trade in the company, David Quinn (CFO since 2020) purchased $436,000 of stock on the 3rd December. Leonard Lemoine (Non-Executive Director) bought $189,000 of stock, Lonnie Boyer (CEO since 2017) purchased $60,000 and Gary Cappa […]

Read More

$MRVI US Maravai Lifesciences ranked positive on Dec 1st 2020

Carl Hull (Co-founder and CEO since 2014) purchased $942,000 of stock on the 25th of November at $26.94. The company recently floated at $27. There was significant subscription by both directors and executives in the IPO with 5 directors spending in total over $3 million and 2 executives spending in total over $700,000. The number […]

Read More

$MS US Morgan Stanley ranked positive on Nov 17th 2020

Hutham Olayan (Director since 2006) purchased 25,000 shares on November 12th at $55.40, spending $1.4m and increasing her holdings to 218,478 shares. This is Olayan’s third open market buy since joining the board 14 years ago and is by far her largest. Her last purchase was in 2011 at $20. We were also intrigued to […]

Read More

$DNB Dun & Bradstreet ranked positive on Nov 10th 2020

Anthony Jabbour (CEO since 2020) purchased $1 million of stock on the 6th of November at $26.31. This is his first purchase since the IPO in July 2020 when he subscribed for $4.4 million at $22. He only made 3 purchases when CEO at Black Knight but they were well-timed. Bryan Hipsher (CFO since 2020) […]

Read More

$PTVI US Pactiv Evergreen ranked positive on Nov 25th 2020

After seeing a cluster of four directors, the Chairman, a Divisional President, the CEO and CFO all buy shares on September 21st, one of the buyers, Allen Hugli (Director) has made an additional purchase spending $160,000 at $15.97. This is a solid show of confidence from board members and officers, and a mixture of buying […]

Read More

Why didn’t we negatively rank Pfizer $PFE US on the recent CEO Share sale?

Albert Bourla’s sale of $5.5m of stock on the announcement of Pfizer’s Covid-19 vaccine success generated significant headlines as it represented 62% of his equity holding. When ranking stocks a key point we look at is the sale relative to their total holding. In the US executives typically have options that are exercisable to become […]

Read More